ATE438381T1 - Zolpidemtabletten - Google Patents
ZolpidemtablettenInfo
- Publication number
- ATE438381T1 ATE438381T1 AT06818692T AT06818692T ATE438381T1 AT E438381 T1 ATE438381 T1 AT E438381T1 AT 06818692 T AT06818692 T AT 06818692T AT 06818692 T AT06818692 T AT 06818692T AT E438381 T1 ATE438381 T1 AT E438381T1
- Authority
- AT
- Austria
- Prior art keywords
- zolpideme
- tablets
- tablet
- designed
- dosage form
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 abstract 1
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001475 zolpidem Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Buildings Adapted To Withstand Abnormal External Influences (AREA)
- Pyridine Compounds (AREA)
- Refuge Islands, Traffic Blockers, Or Guard Fence (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73781105P | 2005-11-18 | 2005-11-18 | |
| PCT/EP2006/011131 WO2007065559A1 (en) | 2005-11-18 | 2006-11-20 | Zolpidem tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE438381T1 true ATE438381T1 (de) | 2009-08-15 |
Family
ID=37714593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06818692T ATE438381T1 (de) | 2005-11-18 | 2006-11-20 | Zolpidemtabletten |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8148393B2 (de) |
| EP (1) | EP1948132B1 (de) |
| KR (1) | KR101345468B1 (de) |
| AT (1) | ATE438381T1 (de) |
| AU (1) | AU2006322314A1 (de) |
| CA (1) | CA2629740A1 (de) |
| DE (1) | DE602006008339D1 (de) |
| WO (1) | WO2007065559A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR056633A1 (es) * | 2005-12-07 | 2007-10-17 | Gador Sa | Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones |
| SG10201610869TA (en) | 2012-06-26 | 2017-02-27 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalacti |
| EP2983674A4 (de) | 2013-04-08 | 2017-05-10 | Dennis M. Brown | Therapeutischer nutzen suboptimal verabreichter chemischer verbindungen |
| CA2928568A1 (en) | 2013-07-26 | 2015-01-29 | Update Pharma Inc. | Combinatorial methods to improve the therapeutic benefit of bisantrene |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2736682A (en) | 1954-10-11 | 1956-02-28 | Victor M Hermelin | Method of making a prolonged action medicinal tablet |
| US3048526A (en) | 1958-08-04 | 1962-08-07 | Wander Company | Medicinal tablet |
| US3388041A (en) | 1964-01-27 | 1968-06-11 | Richardson Merrell Inc | High dosage sustained release tablet |
| US3862140A (en) | 1972-05-08 | 1975-01-21 | Warner Lambert Co | 4-hydroxy-2h- 1-benzothiopyran-3-carboxamide 1,1-dioxides |
| FR2492382A1 (fr) | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
| DE3435325A1 (de) * | 1983-04-09 | 1986-04-17 | Nikken Chemicals Co., Ltd., Tokio/Tokyo | Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung |
| US4626538A (en) | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| SE8404467D0 (sv) | 1984-09-06 | 1984-09-06 | Ferrosan Ab | Controlled-release medical preparations |
| US4948592A (en) | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
| FR2600650B1 (fr) | 1986-06-27 | 1988-09-09 | Synthelabo | Procede de preparation d'imidazopyridines et composes intermediaires |
| US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
| IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
| DK0472502T3 (da) | 1990-08-24 | 1995-10-09 | Spirig Ag | Fremgangsmåde til fremstilling af pellets |
| US5178867A (en) | 1991-08-19 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug in short-time period |
| IT1264696B1 (it) | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
| GB9401894D0 (en) | 1994-02-01 | 1994-03-30 | Rhone Poulenc Rorer Ltd | New compositions of matter |
| GB9407386D0 (en) * | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
| IT1276522B1 (it) | 1995-04-07 | 1997-10-31 | Elena Benincasa | Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei |
| US5773031A (en) | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
| FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| EP1005863A1 (de) | 1998-12-04 | 2000-06-07 | Synthelabo | Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| EP1038875B1 (de) | 1999-03-25 | 2003-06-04 | Synthon B.V. | Imidazopyridinderivate und Verfahren zu ihrer Herstellung |
| EP1064937A1 (de) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze |
| JP4637338B2 (ja) * | 2000-09-22 | 2011-02-23 | 大塚製薬株式会社 | シロスタゾール有核錠 |
| US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
-
2006
- 2006-11-20 DE DE602006008339T patent/DE602006008339D1/de active Active
- 2006-11-20 AU AU2006322314A patent/AU2006322314A1/en not_active Abandoned
- 2006-11-20 KR KR1020087014676A patent/KR101345468B1/ko not_active Expired - Fee Related
- 2006-11-20 AT AT06818692T patent/ATE438381T1/de not_active IP Right Cessation
- 2006-11-20 EP EP06818692A patent/EP1948132B1/de active Active
- 2006-11-20 CA CA002629740A patent/CA2629740A1/en not_active Abandoned
- 2006-11-20 US US11/561,737 patent/US8148393B2/en not_active Expired - Fee Related
- 2006-11-20 WO PCT/EP2006/011131 patent/WO2007065559A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007065559A1 (en) | 2007-06-14 |
| KR20080073342A (ko) | 2008-08-08 |
| CA2629740A1 (en) | 2007-06-14 |
| EP1948132B1 (de) | 2009-08-05 |
| US20070166380A1 (en) | 2007-07-19 |
| EP1948132A1 (de) | 2008-07-30 |
| KR101345468B1 (ko) | 2013-12-30 |
| DE602006008339D1 (en) | 2009-09-17 |
| AU2006322314A1 (en) | 2007-06-14 |
| US8148393B2 (en) | 2012-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR114143A2 (es) | Formulaciones de comprimidos revestidos | |
| FR2883179B1 (fr) | Comprime enrobe | |
| AR059194A1 (es) | Formas de dosificacion resistentes a la manipulacion | |
| BRPI0820997A2 (pt) | Comprimidos de desintegração oral compreendendo difenidramina. | |
| BRPI0606339A2 (pt) | formas farmacêuticas resistentes a álcool | |
| DK4218732T3 (da) | Tabletter omfattende eltrombopag-olamin | |
| FR2936709B1 (fr) | Comprimes alcoolo-resistants. | |
| DK2399579T3 (da) | Farmaceutiske doseringsformer | |
| EP2329812A4 (de) | Filmbeschichtete gekerbte tablette | |
| TW201711676A (en) | Ferric citrate dosage forms | |
| NO20074037L (no) | Farmasoytiske formuleringer med vedvarende frigivelse | |
| DK200900115U1 (en) | Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor | |
| DE602007005372D1 (de) | Zweischichtige tablette zur verhinderung von kardiovaskulären ereignissen | |
| DK1871181T3 (da) | Kosttilskud til HIV-patienter | |
| EP2356989A4 (de) | Stabile tablette mit 4,5-epoxymorphinan-derivat | |
| DK2007384T3 (da) | Orodispergerbare domperidontabletter | |
| EA200900958A1 (ru) | Препарат невирапина пролонгированного высвобождения | |
| EP2033643A4 (de) | Komprimierte zubereitung | |
| CL2008001014A1 (es) | Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol. | |
| WO2007141743A3 (en) | A tablet dosage form comprising cetirizine and pseudoephedrine | |
| EP1961413A4 (de) | Schnell zerfallende orale tablette | |
| DE602006008339D1 (en) | Zolpidemtabletten | |
| EP2050456A4 (de) | Tablette | |
| DK1720557T3 (da) | Hurtig-opløselig, smagsmaskeret tablet | |
| UA37553U (uk) | Кристалічна структура лікарського препарату у формі таблеток на основі міансерину гідрохлориду |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |